drugset / Trial / NCT03663465

The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics

NCT03663465

Completed 135 enrolled Calo Psychiatric Center
Non-randomizedParallel-groupDouble-blindPrevention

Summary

Importance: The problems of side effects of metabolic disturbances in schizophrenic patients have been of worldwide concern for some time. Patients with dyslipidemia have an increased risk of cardiovascular diseases. A Chinese herb, Hawthorn, is widely used for the treatment of dyslipidemia. Objective: Therefore, this study aimed to investigate the effect of Hawthorn on lipid profile levels in schizophrenic patients treated with antipsychotics. Design, Setting, and Participants: A longitudinal case-control study was used in a general hospital in Taiwan. A total of 59 schizophrenics treated with antipsychotics, and 76 healthy adult subjects, who were all hospital workers, were enrolled in this study. Main outcomes and measures: All participants received Hawthorn at a dose of 3 gm/day for six months.

Timeline

Start
2013-01-01
Primary completion
2013-12-31
Completion
2014-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Hawthorn Traditional medicine (herbal / TCM) 3 g

Indications